Lehmann, Brian D. http://orcid.org/0000-0003-0407-5248
Colaprico, Antonio
Silva, Tiago C. http://orcid.org/0000-0003-1343-6850
Chen, Jianjiao http://orcid.org/0000-0001-5438-3236
An, Hanbing
Ban, Yuguang http://orcid.org/0000-0002-2874-0647
Huang, Hanchen
Wang, Lily
James, Jamaal L.
Balko, Justin M. http://orcid.org/0000-0002-4263-5974
Gonzalez-Ericsson, Paula I. http://orcid.org/0000-0002-6292-6963
Sanders, Melinda E.
Zhang, Bing http://orcid.org/0000-0001-8676-2425
Pietenpol, Jennifer A.
Chen, X. Steven
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA200987, R01CA158472, U24CA210954, P30CA068485, P50CA098131)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Susan G. Komen (CCR13262005, SAC110030)
U.S. Department of Defense (BC201286)
Article History
Received: 10 September 2020
Accepted: 8 October 2021
First Online: 1 November 2021
Competing interests
: X.C., B.D.L. and J.A.P. are inventors (PCT/US2012/065724) of intellectual property (TNBCtype) licensed by Insight Genetics Inc. J.M.B. receives research support from Genentech/Roche, Bristol Myers Squibb, and Incyte Corporation, has received consulting/expert witness fees from Novartis, and is an inventor on provisional patents regarding immunotherapy targets and biomarkers in cancer. The remaining authors declare no competing interests.